60 DEGREES PHARMACEUTICALS, INC. Net Fee Amt
60 DEGREES PHARMACEUTICALS, INC. (SXTP) had Net Fee Amt of $283.48 as of 2026-08-13, per its S-3 filed 2026-08-14.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-08-14
- 2026-08-13: Net Fee Amt $283.48.
| Period end | Net Fee Amt |
|---|---|
| 2026-08-13 | $283.48 S-3 · filed 2026-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 |